The factors influencing the unmet effects of alpha hydroxy acid peels on acne vulgaris: A single tertiary center experience

2021 ◽  
Author(s):  
Jieying Tang ◽  
Jianmin Yang ◽  
Cuicui Zhang ◽  
Xuemei Zhang ◽  
Qiang Chen ◽  
...  

2007 ◽  
Vol 34 (1) ◽  
pp. 45-51 ◽  
Author(s):  
EDWARD KESSLER ◽  
KATHERINE FLANAGAN ◽  
CHRISTINA CHIA ◽  
CYNTHIA ROGERS ◽  
DEE ANNA GLASER


2019 ◽  
Vol 23 (1) ◽  
pp. 7 ◽  
Author(s):  
NahlaKhamis Ibrahim ◽  
SarahAbdulaziz Nagadi ◽  
HaifaJamal Idrees ◽  
LogainGhazi Alghanemi ◽  
RawanIshaq Essa ◽  
...  


2008 ◽  
Vol 34 (1) ◽  
pp. 45-51 ◽  
Author(s):  
EDWARD KESSLER ◽  
KATHERINE FLANAGAN ◽  
CHRISTINA CHIA ◽  
CYNTHIA ROGERS ◽  
DEE ANNA GLASER


2018 ◽  
Vol 34 ◽  
pp. 50-55 ◽  
Author(s):  
A. Gonzalez Fiol ◽  
M-L. Meng ◽  
V. Danhakl ◽  
M. Kim ◽  
R. Miller ◽  
...  




Toxins ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 511
Author(s):  
Carolina Gorodetsky ◽  
Paula Azevedo ◽  
Carolina Candeias da Silva ◽  
Alfonso Fasano

There is no available data on the journey of dystonia patients once referred to a tertiary center to undergo deep brain stimulation (DBS). We hypothesized that some patients might be incorrectly diagnosed while others might decline the procedure or experience significant benefit with switching to a different botulinum neurotoxin (BoNT). This is a single-center, retrospective study of dystonia patients who were referred to the DBS program between January 2014 and December 2018. We collected data on the surgical decision as well as factors influencing this decision. Sixty-seven patients were included (30 males, mean age: 48.3 ± 20.1 years, disease duration: 16.9 ± 15.3 years). Thirty-three (49%) patients underwent DBS. Four (6%) patients were awaiting the procedure while the remaining 30 patients (45%) did not undergo DBS. Reasons for DBS decline were patient refusal (17, 53%), functional dystonia (6, 20%), and successful use of AbobotulinumtoxinA (3, 10%) in patients who had failed other BoNTs. Our study highlights the importance of structured patient education to increase acceptance of DBS, as well as careful patient evaluation, particularly with respect to functional dystonia. Finally, changing BoNT formulation might be beneficial in some patients.



Author(s):  
Julie A. Martini ◽  
Robert H. Doremus

Tracy and Doremus have demonstrated chemical bonding between bone and hydroxylapatite with transmission electron microscopy. Now researchers ponder how to improve upon this bond in turn improving the life expectancy and biocompatibility of implantable orthopedic devices.This report focuses on a study of the- chemical influences on the interfacial integrity and strength. Pure hydroxylapatite (HAP), magnesium doped HAP, strontium doped HAP, bioglass and medical grade titanium cylinders were implanted into the tibial cortices of New Zealand white rabbits. After 12 weeks, the implants were retrieved for a scanning electron microscopy study coupled with energy dispersive spectroscopy.Following sacrifice and careful retrieval, the samples were dehydrated through a graduated series starting with 50% ethanol and continuing through 60, 70, 80, 90, 95, and 100% ethanol over a period of two days. The samples were embedded in LR White. Again a graduated series was used with solutions of 50, 75 and 100% LR White diluted in ethanol.



Sign in / Sign up

Export Citation Format

Share Document